FDA approves first medication for obstructive sleep apnea, which also promotes weight loss

Dr. Wendy Troxel discusses how light exercise in the evening can improve sleep quality, while the FDA approves the first medication, Zepbound, for obstructive sleep apnea in adults with obesity. The drug, paired with diet and exercise, activates hormones to reduce appetite and body weight, leading to improvements in OSA symptoms. Zepbound may cause side effects and should not be used by patients with specific medical histories, emphasizing the importance of consulting a doctor before starting treatment.

Full Article